The compulsory licence on sorafenib: A right step to ensure access to medicines
K. M. Gopakumar | TWN | | Third World Resurgence No. 259 | March 2012, pp 26-28 The Indian Patent Office (IPO) made a landmark order on 12 March to grant domestic drug company Natco Pharma a compulsory licence (CL) to… Continue reading


